In addition, certain non-neutralizing mAbs targeting the CCHFV GP38 domain could also protect mice from lethal infection [18,21,22], and are therefore worth considering for CCHF treatment, either used alone or combined with nAbs. This evidence concerns the gene PDPN and infection.